Efeitos sedativos e cardiorrespiratórios da dexmedetomidina isolada ou associada à acepromazina em felinos saudáveis

Detalhes bibliográficos
Ano de defesa: 2024
Autor(a) principal: Schimites, Paula Ivanir
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
dARK ID: ark:/26339/001300001c73n
Idioma: por
Instituição de defesa: Universidade Federal de Santa Maria
Brasil
Medicina Veterinária
UFSM
Programa de Pós-Graduação em Medicina Veterinária
Centro de Ciências Rurais
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Cat
Link de acesso: http://repositorio.ufsm.br/handle/1/33393
Resumo: This thesis was divided into two sections. The first section refers to a retrospective study manuscript of anesthetic records in felines from February 2022 to February 2023, carried out at the Veterinary University Hospital of the Federal University of Santa Maria - RS, with the aim of determining the frequency of dexmedetomidine's use, possible associations with other drugs, dose used and the impact on dose reduction of other anesthetics. A total of 358 medical records were analyzed, of which 126 (35%) had protocols with dexmedetomidine (median dose of 4.0 µg/kg) alone (9/126 cases, 7%) or in association with drugs such as opioids and dissociatives ( 55/126 cases, 44%), followed by the association with opioids only (49/126 cases, 39%), associated with dissociatives only (6/126 cases, 5%) and other less frequent associations. According to the study, there was no influence of the protocol used as preanesthetic medication on the need or not to use doses higher than 3 mg/kg of propofol for anesthetic induction in felines sedated with dexmedetomidine associated or not with other pharmacological classes and with or without the use of co-inducers. According to the study, there was no influence of the protocol used as pre-anesthetic medication on the need or not to use doses higher than 3 mg/kg of propofol for anesthetic induction in felines sedated with dexmedetomidine associated or not with other pharmacological classes and with or without the use of co-inducers. The second section refers to a published scientific article that aimed to investigate the sedative potential, incidence of emesis and cardiovascular changes in two groups of healthy felines submitted to outpatient sedation with dexmedetomidine alone or associated with acepromazine. Fourteen healthy adult male felines were included in the study, divided into two experimental treatments: GD (dexmedetomidine 5 µg/kg IM, n=7) and GDA (dexmedetomidine 5 µg/kg + acepromazine 0.03 mg/kg IM, n=7), with the volume of the treatments diluted with NaCl 0.9% to a total of 0.5 mL. Assessments began 20 minutes after sedation by a blinded evaluator, who recorded sedation scores (0 = no sedation; 1 = able to remain standing but staggering; 2 = sternal recumbency; 3 = able to raise head; and 4 = lateral recumbency unresponsive to clapping), episodes of emesis, heart rate (HR), respiratory rate (FR), rectal temperature, and systolic arterial pressure (SAP). The variables were collected at 20 minutes after sedation and every 10 minutes until they returned to baseline levels. At baseline and at T30, venous blood samples were collected for blood gas analysis. At T20, HR was significantly lower in GDA compared to GD and SAP was significantly lower in both groups compared to baseline. The time of sedation was similar between groups, although sedation scores differed significantly at T20, with 1 (0–4) in GD and 4 (4–4) in GDA. More episodes of emesis were recorded in GD compared with GDA. The combination of dexmedetomidine and acepromazine produced deeper sedation with faster onset and a lower incidence of emesis compared with dexmedetomidine alone in healthy cats. The results of this thesis will certainly enrich the scientific literature and contribute to advances and updates in veterinary anesthesiology. Studies will be necessary to evaluate reproducibility for clinical use in hospital routine not just in healthy patients.
id UFSM_67878a1c352fc6bd2a03493c3af0de32
oai_identifier_str oai:repositorio.ufsm.br:1/33393
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Efeitos sedativos e cardiorrespiratórios da dexmedetomidina isolada ou associada à acepromazina em felinos saudáveisSedative and cardiorespiratory effects of dexmedetomidine alone or combined with acepromazine in healthy catsAgonistasα2-adrenérgicosFenotiazínicoÊmeseGatoAgonistsα2-adrenergicPhenothiazineEmesisSedationCatCNPQ::CIENCIAS AGRARIAS::MEDICINA VETERINARIAThis thesis was divided into two sections. The first section refers to a retrospective study manuscript of anesthetic records in felines from February 2022 to February 2023, carried out at the Veterinary University Hospital of the Federal University of Santa Maria - RS, with the aim of determining the frequency of dexmedetomidine's use, possible associations with other drugs, dose used and the impact on dose reduction of other anesthetics. A total of 358 medical records were analyzed, of which 126 (35%) had protocols with dexmedetomidine (median dose of 4.0 µg/kg) alone (9/126 cases, 7%) or in association with drugs such as opioids and dissociatives ( 55/126 cases, 44%), followed by the association with opioids only (49/126 cases, 39%), associated with dissociatives only (6/126 cases, 5%) and other less frequent associations. According to the study, there was no influence of the protocol used as preanesthetic medication on the need or not to use doses higher than 3 mg/kg of propofol for anesthetic induction in felines sedated with dexmedetomidine associated or not with other pharmacological classes and with or without the use of co-inducers. According to the study, there was no influence of the protocol used as pre-anesthetic medication on the need or not to use doses higher than 3 mg/kg of propofol for anesthetic induction in felines sedated with dexmedetomidine associated or not with other pharmacological classes and with or without the use of co-inducers. The second section refers to a published scientific article that aimed to investigate the sedative potential, incidence of emesis and cardiovascular changes in two groups of healthy felines submitted to outpatient sedation with dexmedetomidine alone or associated with acepromazine. Fourteen healthy adult male felines were included in the study, divided into two experimental treatments: GD (dexmedetomidine 5 µg/kg IM, n=7) and GDA (dexmedetomidine 5 µg/kg + acepromazine 0.03 mg/kg IM, n=7), with the volume of the treatments diluted with NaCl 0.9% to a total of 0.5 mL. Assessments began 20 minutes after sedation by a blinded evaluator, who recorded sedation scores (0 = no sedation; 1 = able to remain standing but staggering; 2 = sternal recumbency; 3 = able to raise head; and 4 = lateral recumbency unresponsive to clapping), episodes of emesis, heart rate (HR), respiratory rate (FR), rectal temperature, and systolic arterial pressure (SAP). The variables were collected at 20 minutes after sedation and every 10 minutes until they returned to baseline levels. At baseline and at T30, venous blood samples were collected for blood gas analysis. At T20, HR was significantly lower in GDA compared to GD and SAP was significantly lower in both groups compared to baseline. The time of sedation was similar between groups, although sedation scores differed significantly at T20, with 1 (0–4) in GD and 4 (4–4) in GDA. More episodes of emesis were recorded in GD compared with GDA. The combination of dexmedetomidine and acepromazine produced deeper sedation with faster onset and a lower incidence of emesis compared with dexmedetomidine alone in healthy cats. The results of this thesis will certainly enrich the scientific literature and contribute to advances and updates in veterinary anesthesiology. Studies will be necessary to evaluate reproducibility for clinical use in hospital routine not just in healthy patients.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESEsta tese foi dividida em duas partes. A primeira parte gerou um manuscrito referente a um estudo retrospectivo de prontuários anestésicos em felinos no período de fevereiro de 2022 a fevereiro de 2023, realizados no Hospital Veterinário Universitário da Universidade Federal de Santa Maria - RS, com o objetivo de determinar a frequência do emprego de dexmedetomidina, possíveis associações a outros fármacos, dose empregada e o impacto para redução de doses de outros anestésicos. No total 358 prontuários foram analisados, desses 126 (35%) possuíam protocolos com dexmedetomidina (dose mediana de 4,0 µg/kg) isoladamente (9/126 casos, 7%) ou em associação a fármacos como opioides e dissociativos (55/126 casos, 44%), seguida da associação apenas a opioides (49/126 casos, 39%), associada apenas a dissociativos (6/126 casos, 5%) e outras associações de menor frequência. De acordo com o estudo, não houve influência do protocolo utilizado como medicação pré-anestésica sobre a necessidade ou não de se utilizar doses superiores a 3 mg/kg de propofol para indução anestésica em felinos sedados com dexmedetomidina associada ou não a outras classes farmacológicas e com emprego ou não de coindutores. A segunda parte gerou um artigo científico e objetivou investigar o potencial sedativo, a incidência de êmese e alterações cardiovasculares em dois grupos de felinos submetidos à sedação ambulatorial com dexmedetomidina isolada ou associada à acepromazina. Foram utilizados 14 felinos machos adultos saudáveis, divididos em dois tratamentos experimentais: GD (dexmedetomidina 5 µg/kg IM, n=7) e GDA (dexmedetomidina 5 µg/kg + acepromazina 0,03 mg/kg IM, n=7), sendo o volume dos tratamentos diluído com NaCl 0,9% até um total de 0,5 mL. Posteriormente à avaliação basal, as próximas avaliações iniciaram somente 20 minutos após a sedação, sempre pelo mesmo avaliador encoberto, que pontuou escore de sedação (0 = ausência de sedação; 1 = capaz de permanecer em estação, porém cambaleante; 2 = decúbito esternal; 3 = capaz de elevar a cabeça; e 4 = decúbito lateral irresponsivo ao bater de palmas), episódios de êmese, frequência cardíaca (FC), frequência respiratória (f), temperatura retal e pressão arterial sistólica (PAS). As variáveis foram colhidas aos 20 minutos após a sedação e a cada 10 minutos até seu retorno aos níveis basais. No momento basal e em M30 foram colhidas amostras de sangue venoso para avaliação hemogasométrica. No M20, a FC foi significativamente menor no GDA comparado ao GD e a PAS foi significativamente menor em ambos os grupos em comparação com o valor basal. A duração da sedação foi semelhante entre os grupos, embora os escores de sedação tenham diferido significativamente em M20, com 1 (0–4) no GD e 4 (4–4) no GDA. Mais episódios de êmese foram registrados no GD em comparação com o GDA. A combinação de dexmedetomidina e acepromazina produziu sedação mais profunda com início mais rápido e menor incidência de êmese em comparação com a dexmedetomidina isoladamente em gatos saudáveis. Estudos serão necessários para avaliar a reprodutibilidade para uso clínico na rotina hospitalar além de pacientes hígidos.Universidade Federal de Santa MariaBrasilMedicina VeterináriaUFSMPrograma de Pós-Graduação em Medicina VeterináriaCentro de Ciências RuraisSoares, André Vasconceloshttp://lattes.cnpq.br/1413221301096456Brun , Mauricio VelosoFloriano, Beatriz PerezFreitas, Gabrielle CoelhoSegat, Hecson JesserOliveira, Marília Teresa deSchimites, Paula Ivanir2024-11-21T15:08:34Z2024-11-21T15:08:34Z2024-09-19info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/33393ark:/26339/001300001c73nporAttribution-NonCommercial-NoDerivatives 4.0 Internationalinfo:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2024-11-22T18:04:59Zoai:repositorio.ufsm.br:1/33393Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/PUBhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.com||manancial@ufsm.bropendoar:2024-11-22T18:04:59Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Efeitos sedativos e cardiorrespiratórios da dexmedetomidina isolada ou associada à acepromazina em felinos saudáveis
Sedative and cardiorespiratory effects of dexmedetomidine alone or combined with acepromazine in healthy cats
title Efeitos sedativos e cardiorrespiratórios da dexmedetomidina isolada ou associada à acepromazina em felinos saudáveis
spellingShingle Efeitos sedativos e cardiorrespiratórios da dexmedetomidina isolada ou associada à acepromazina em felinos saudáveis
Schimites, Paula Ivanir
Agonistas
α2-adrenérgicos
Fenotiazínico
Êmese
Gato
Agonists
α2-adrenergic
Phenothiazine
Emesis
Sedation
Cat
CNPQ::CIENCIAS AGRARIAS::MEDICINA VETERINARIA
title_short Efeitos sedativos e cardiorrespiratórios da dexmedetomidina isolada ou associada à acepromazina em felinos saudáveis
title_full Efeitos sedativos e cardiorrespiratórios da dexmedetomidina isolada ou associada à acepromazina em felinos saudáveis
title_fullStr Efeitos sedativos e cardiorrespiratórios da dexmedetomidina isolada ou associada à acepromazina em felinos saudáveis
title_full_unstemmed Efeitos sedativos e cardiorrespiratórios da dexmedetomidina isolada ou associada à acepromazina em felinos saudáveis
title_sort Efeitos sedativos e cardiorrespiratórios da dexmedetomidina isolada ou associada à acepromazina em felinos saudáveis
author Schimites, Paula Ivanir
author_facet Schimites, Paula Ivanir
author_role author
dc.contributor.none.fl_str_mv Soares, André Vasconcelos
http://lattes.cnpq.br/1413221301096456
Brun , Mauricio Veloso
Floriano, Beatriz Perez
Freitas, Gabrielle Coelho
Segat, Hecson Jesser
Oliveira, Marília Teresa de
dc.contributor.author.fl_str_mv Schimites, Paula Ivanir
dc.subject.por.fl_str_mv Agonistas
α2-adrenérgicos
Fenotiazínico
Êmese
Gato
Agonists
α2-adrenergic
Phenothiazine
Emesis
Sedation
Cat
CNPQ::CIENCIAS AGRARIAS::MEDICINA VETERINARIA
topic Agonistas
α2-adrenérgicos
Fenotiazínico
Êmese
Gato
Agonists
α2-adrenergic
Phenothiazine
Emesis
Sedation
Cat
CNPQ::CIENCIAS AGRARIAS::MEDICINA VETERINARIA
description This thesis was divided into two sections. The first section refers to a retrospective study manuscript of anesthetic records in felines from February 2022 to February 2023, carried out at the Veterinary University Hospital of the Federal University of Santa Maria - RS, with the aim of determining the frequency of dexmedetomidine's use, possible associations with other drugs, dose used and the impact on dose reduction of other anesthetics. A total of 358 medical records were analyzed, of which 126 (35%) had protocols with dexmedetomidine (median dose of 4.0 µg/kg) alone (9/126 cases, 7%) or in association with drugs such as opioids and dissociatives ( 55/126 cases, 44%), followed by the association with opioids only (49/126 cases, 39%), associated with dissociatives only (6/126 cases, 5%) and other less frequent associations. According to the study, there was no influence of the protocol used as preanesthetic medication on the need or not to use doses higher than 3 mg/kg of propofol for anesthetic induction in felines sedated with dexmedetomidine associated or not with other pharmacological classes and with or without the use of co-inducers. According to the study, there was no influence of the protocol used as pre-anesthetic medication on the need or not to use doses higher than 3 mg/kg of propofol for anesthetic induction in felines sedated with dexmedetomidine associated or not with other pharmacological classes and with or without the use of co-inducers. The second section refers to a published scientific article that aimed to investigate the sedative potential, incidence of emesis and cardiovascular changes in two groups of healthy felines submitted to outpatient sedation with dexmedetomidine alone or associated with acepromazine. Fourteen healthy adult male felines were included in the study, divided into two experimental treatments: GD (dexmedetomidine 5 µg/kg IM, n=7) and GDA (dexmedetomidine 5 µg/kg + acepromazine 0.03 mg/kg IM, n=7), with the volume of the treatments diluted with NaCl 0.9% to a total of 0.5 mL. Assessments began 20 minutes after sedation by a blinded evaluator, who recorded sedation scores (0 = no sedation; 1 = able to remain standing but staggering; 2 = sternal recumbency; 3 = able to raise head; and 4 = lateral recumbency unresponsive to clapping), episodes of emesis, heart rate (HR), respiratory rate (FR), rectal temperature, and systolic arterial pressure (SAP). The variables were collected at 20 minutes after sedation and every 10 minutes until they returned to baseline levels. At baseline and at T30, venous blood samples were collected for blood gas analysis. At T20, HR was significantly lower in GDA compared to GD and SAP was significantly lower in both groups compared to baseline. The time of sedation was similar between groups, although sedation scores differed significantly at T20, with 1 (0–4) in GD and 4 (4–4) in GDA. More episodes of emesis were recorded in GD compared with GDA. The combination of dexmedetomidine and acepromazine produced deeper sedation with faster onset and a lower incidence of emesis compared with dexmedetomidine alone in healthy cats. The results of this thesis will certainly enrich the scientific literature and contribute to advances and updates in veterinary anesthesiology. Studies will be necessary to evaluate reproducibility for clinical use in hospital routine not just in healthy patients.
publishDate 2024
dc.date.none.fl_str_mv 2024-11-21T15:08:34Z
2024-11-21T15:08:34Z
2024-09-19
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/33393
dc.identifier.dark.fl_str_mv ark:/26339/001300001c73n
url http://repositorio.ufsm.br/handle/1/33393
identifier_str_mv ark:/26339/001300001c73n
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Medicina Veterinária
UFSM
Programa de Pós-Graduação em Medicina Veterinária
Centro de Ciências Rurais
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Medicina Veterinária
UFSM
Programa de Pós-Graduação em Medicina Veterinária
Centro de Ciências Rurais
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com||manancial@ufsm.br
_version_ 1847153502640406528